INR 82.0
(-0.5%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 39.22 Million | 29.4 Million | -38.36 Million | 24.74 Million | 34.41 Million | 24.3 Million |
Net Income | 17.41 Million | 2.34 Million | 10.87 Million | 8.49 Million | 6.09 Million | 7.17 Million |
Depreciation & Amortization | 15.84 Million | 11.92 Million | 11.21 Million | 10.2 Million | 9.86 Million | 7.69 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -11.77 Million | -13.36 Million | -99.58 Million | -70.22 Million | 11.6 Million | -11.14 Million |
Other non-cash items | 17.73 Million | 28.49 Million | 39.12 Million | 76.26 Million | 6.85 Million | 20.58 Million |
Investing Cash Flow | -17.8 Million | -28.63 Million | -5.97 Million | -7.91 Million | -5.97 Million | -19.51 Million |
Investments in PPE | -17.85 Million | -30.06 Million | -5.97 Million | -7.89 Million | -6.49 Million | -19.48 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 46.53 Thousand | 1.42 Million | - | -18 Thousand | 513.13 Thousand | -27.52 Thousand |
Financing Cash Flow | -20.75 Million | -746.8 Thousand | 44.41 Million | -16.87 Million | -28.39 Million | -4.73 Million |
Debt repayment | -8.6 Million | -2.03 Million | -1.41 Million | -9.94 Million | -4.6 Million | -8.8 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -29.36 Million | -2.78 Million | 43 Million | -26.82 Million | -23.79 Million | 4.07 Million |
Accounts receivables | 17.19 Million | -37.74 Million | -94.95 Million | 19.06 Million | -26.4 Million | -15.99 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | -39.81 Million | 19.49 Million | -40.73 Million | -37.27 Million | 32.57 Million | -11.87 Million |
Other working capital | 10.83 Million | 4.88 Million | 36.09 Million | -52.01 Million | 5.43 Million | 16.73 Million |
Cash at beginning of period | 231.84 Thousand | 208.75 Thousand | 132.5 Thousand | 177.42 Thousand | 136.9 Thousand | 70.7 Thousand |
Cash at end of period | 891.2 Thousand | 231.84 Thousand | 208.75 Thousand | 132.5 Thousand | 177.42 Thousand | 136.9 Thousand |
Capital Expenditure | -17.85 Million | -30.06 Million | -5.97 Million | -7.89 Million | -6.49 Million | -19.48 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 659.36 Thousand | 23.09 Thousand | 76.25 Thousand | -44.92 Thousand | 40.51 Thousand | 66.2 Thousand |
Free Cash Flow | 21.36 Million | -653.49 Thousand | -44.34 Million | 16.84 Million | 27.92 Million | 4.82 Million |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -17.8 Million | 17.41 Million | -8.98 Million | 14.82 Million | 31.92 Million | -20.34 Million |
Depreciation & Amortization | - | 15.85 Million | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -11.78 Million | - | - | - | - |
Other non-cash items | 17.8 Million | 17.73 Million | 8.98 Million | -14.82 Million | -31.92 Million | 20.34 Million |
Investing Cash Flow | - | -17.8 Million | - | - | - | - |
Investments in PPE | - | -17.85 Million | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | 47 Thousand | - | - | - | - |
Financing Cash Flow | - | -20.75 Million | - | - | - | - |
Debt repayment | - | -8.6 Million | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -29.36 Million | - | - | - | - |
Accounts receivables | - | 17.19 Million | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | -39.81 Million | - | - | - | - |
Other working capital | - | 10.83 Million | - | - | - | - |
Cash at beginning of period | - | 231.84 Thousand | - | - | - | - |
Cash at end of period | - | 891 Thousand | - | - | - | - |
Capital Expenditure | - | -17.85 Million | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | 659.16 Thousand | - | - | - | - |
Free Cash Flow | - | 21.36 Million | - | - | - | - |
300223
7205
ACME
SURANAT&P
300965
CGVAK